Transcat Q2 2024 Earnings Call Transcript

There are 6 speakers on the call.

Operator

Greetings. Welcome to Transcat Inc. 2nd Quarter Fiscal 20 24 Financial Results. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation.

Operator

Please note this conference is being recorded. I will now turn the conference over to Todd Barbato, CFO. Thank you. You may begin.

Speaker 1

Thank you, operator, and good morning, everyone. We appreciate your time and your interest in Transcat. With me here on the call today is our President and CEO, Lee Rudow and our Chief Operating Officer, Mark Doheny. We will begin the call with some prepared remarks, and then we'll open up the call for questions. Our earnings release crossed the wire after the market closed yesterday.

Speaker 1

Both the earnings release and the slides that we will reference During our prepared remarks can be found on our website, transcat.com, in the Investor Relations section. If you would, please refer to Slide 2. As you are aware, we may make forward looking statements during the formal presentation and Q and A portion of this teleconference. These statements apply to future events, which are subject to risks and uncertainties, as well as other factors that could cause the actual results to differ materially from where we are today. These factors are outlined in the news release as well as in the documents filed by the company with the SEC.

Speaker 1

You can find those on our website where we regularly post information about the company as well as on the SEC's website atsec.gov. We undertake No obligation to publicly update or correct any of the forward looking statements contained in this call, whether as a result of new information, Please review our forward looking statements in conjunction with these precautionary factors. Additionally, during today's call, we will discuss certain non GAAP measures, which we believe will be useful in evaluating our performance. You should not consider the presentation of this additional information in isolation or as a substitute for results prepared in accordance with GAAP. We've provided reconciliations of non GAAP to compared GAAP measures in the tables accompanying the earnings release.

Speaker 1

With that, I'll turn the call over to Lee.

Speaker 2

Okay. Thank you, Tom. Good morning, everyone. Thank you for joining us on the call today. Transcat delivered strong performance across our entire business portfolio again in the Q2 of fiscal 2024.

Speaker 2

Consolidated revenue Consolidated gross margin expanded 230 basis points to 32% as margins expanded in both our service and distribution segments. Adjusted EBITDA, a key metric for us given our successful acquisition strategy, grew 24% from the prior year to $9,300,000 Operating cash flow in the 2nd quarter was $8,500,000 $16,000,000 year to date. Turning to our Q2 service segment performance, our differentiated suite of services continued to support performance at a very high level. We recorded our 58th straight quarter of year over year service revenue growth. Service revenue grew 17%, including double digit organic service growth of 10%.

Speaker 2

Recurring revenue streams and a differentiated, dependable value proposition continue to foster durability and resiliency in our service growth model. And we continue to benefit from strong demand throughout multiple regulated service industries that include pharmaceutical, Medical device, biomedical and as well aerospace and defense. Service gross margin was 34% in the 2nd quarter, which represents 140 basis point increase over prior year. Margin expansion was primarily driven by leverage on double digit organic growth, increased productivity from automation and significant process improvements throughout our network of calibration labs. Turning to distribution for the 2nd quarter, Gross margins expanded 3 40 basis points from prior year, driven by growth and an increase in mix of our high margin rental business.

Speaker 2

Both core distribution and rentals continue to drive a significant number of leads and opportunities into our service segment, supporting consistent strong organic growth. The combination of products, rentals, along with calibration and NexSys' cost control and optimization services remains unique. We've executed well expanding our addressable markets and our value proposition has never been stronger. Overall, strong performance for Transcat in the Q2 of fiscal 2024. The 24% increase in EBITDA is due in part to our ability to achieve our revenue and cost synergy objectives We start by identifying and acquiring companies that are good strategic fit for Transcat, but those are only the first two steps.

Speaker 2

Whether we acquire an adjacent company to expand our markets, a geographic footprint addition or classic bolt on to our core calibration services, It is through integration that Transcat drives differentiation, and we are very proud of the work our team has done on this front. You can see it in the results, the results of their work as margins and profits increase. And of course, acquisitions will continue to be an important part of our overall growth strategy. In the Q2, we acquired Acxiom Test Equipment Rentals, the largest acquisition in Transcat's history And SteriQual, a life science service company specializing in commissioning, qualification and validation services. Acxiom It's a great synergistic fit with Transcat's traditional rental business that was launched organically in 2015.

Speaker 2

Growth synergies between Acxiom and Transcat's Traditional rental business include go to market selling and marketing strategies with complementary inventories and customer base. We expect the combined rental business to perform well as we capitalize on what we consider a 1 plus 1 equals 3 opportunity. CerroCl expands our addressable market within the Nexa cost control and optimization space. CerroCl also fortifies Next is differentiated single source solutions model, NS3. In addition to the 2 acquisitions in the Q2 of fiscal 2024, Perhaps what stands out most is the completion of a public offering of our common stock, which was used to repay our credit facility.

Speaker 2

The highly successful offering displayed robust demand for Transcat stock among institutional investors who recognize, understand and value our long term demonstrated track record of profitable revenue growth, expansion of addressable markets and sustainable margin improvement. And with that, I'll turn things over to Tom for a more detailed view of our fiscal 2023 Second Quarter results.

Speaker 1

Thanks, Lee. I'll start on Slide 4 of the earnings deck posted on our website, which provides detail regarding our revenue on a consolidated basis and by segment for the Q2 of fiscal 2024. 2nd quarter consolidated revenue of $62,800,000 was up 11% versus prior year on service segment strength and slight growth in

Speaker 2

our distribution business.

Speaker 1

Looking at it by segment, service segment revenue Growth remained very strong at 17%, with 10% of the growth coming organically and the other 7% from acquisition. As Lee mentioned, we continue to see high levels of demand in our services business. Turning to distribution. Revenue of 21,400,000 Grew 1% from the prior year. We continue to see growth in the higher margin rental business, which also benefited from the Acxiom Test Equipment acquisition, which closed in mid second quarter.

Speaker 1

Turning to Slide 5, our consolidated gross profit for the Q1 of $20,100,000 was up 20% from the prior year and our gross margin expanded 2 30 basis points in the Q2. Service gross margin expanded 140 basis points. The service margin increase further demonstrates our ability to benefit from the inherent leverage in our operating model as well as higher levels of technician productivity, supported by continuous improvement initiatives like automation and process streamlining within our networks of labs. Distribution segment gross margin of 28.3% was up 3 40 basis points from the prior year, driven by A larger mix of higher margin rental revenue. Turning to Slide 6, Q2 net income of $500,000 Decreased from the prior year due to a non recurring, non cash charge of $2,800,000 for the previously disclosed Amended Nexa earn out.

Speaker 1

The Nexa earn out agreement was amended to recognize the expanded scope of the Nexa portfolio, which includes the acquisition of Steroquel, And this change is based on current expectations of future business performance. Diluted earnings per share came in at $0.06 The one time earn out charge reduced earnings per share by $0.35 We report adjusted diluted earnings As well to normalize for the impacts of upfront and ongoing acquisition related costs. Q2 adjusted diluted earnings per share of $0.60 increased $0.16 or 36 percent from the prior year. A reconciliation of adjusted diluted earnings per share to diluted earnings per share can be found in the supplemental sections of this presentation. Flipping to Slide 7, where we show our adjusted EBITDA and adjusted EBITDA margin.

Speaker 1

We As we continue to execute on our acquisition strategy, this metric becomes even more important to highlight as it does adjust for one time deal related transactions costs as well as the increased level of non cash expense that will hit our income statement from acquisition purchase accounting. With that in mind, 2nd quarter consolidated adjusted EBITDA of $9,300,000 was up 24% from the same quarter in the prior year, And adjusted EBITDA margin expanded 160 basis points. Full segments had adjusted EBITDA growth compared to last year. As always, a reconciliation of adjusted EBITDA to operating income and net income can be found in the supplemental section of this presentation. Moving to Slide 8, operating free cash flow significantly improved up $10,000,000 versus the prior year.

Speaker 1

We've generated $16,000,000 in operating cash flow in the first half of the fiscal year. Q2 capital expenditures were $600,000 higher than prior year and continue to be centered around service segment capabilities, technology, including automation and future growth projects. Slide 9 highlights our strong balance sheet. At the end of the quarter, we had a total net debt of $52,000,000 with a leverage ratio of 1.37x32000000 available from our credit facility. Subsequent to the end of the quarter, the revolving credit facility was paid off using the funds from the secondary offering, which closed Lastly, we expect to file our 10 Q on November 1.

Speaker 1

And with that, I'll turn it back to you, Lee.

Speaker 2

Thanks, Tom. Transcat has consistently delivered exceptional results throughout the past decade and through various economic cycles. We expect profitable growth and sustainable margin improvement to continue as we increase shareholder value. We expect our successful and unique acquisition strategy to drive synergistic growth opportunities and expand our addressable markets. We expect to leverage continuous process improvement and automation, including robotics, which we're in the very early stages of developing as key enablers to future margin expansion.

Speaker 2

In other words, we expect to get bigger and we expect to get better. That's the Transcat way. As we work our way through the Q3 of fiscal 2024, we are still expecting high single digit to low double digit organic service growth for the full fiscal year, and we expect gross margin expansion as well. Perhaps most importantly, we expect to develop, recruit and retain superior management and leadership throughout our organization. It's the people at Transcat that continue to move the needle and push the company to new heights.

Speaker 2

We expect to continue

Operator

Our first question is from Greg Palm with Craig Hallum Capital Group. Please proceed.

Speaker 3

Yes, thanks. Good morning, everyone. I wanted to start with service gross margin on an absolute basis was Really strong and I think the improvement on a year over year basis was the highest in some time. So I guess It's kind of a continuation of what you've been seeing over the years. But in terms of kind of the greatest positive impacts, Where are you seeing that?

Speaker 3

And should we assume that level of year over year improvements for the remainder of the year? Was there something kind of one time in nature that drove some of that strength

Speaker 2

Okay. Well, I'll take that call, that question, Greg. It's a combination of things that we alluded to. No surprise that strong organic growth is going to always help our margins. There's inherent leverage in this business model.

Speaker 2

We've talked about that through the years. And I think volume helps, volume will continue to help. So to the degree that we continue to grow organically At the rate that we have, you'll see margins improve from that. So also automation, we are now probably In our 3rd or 4th year of focusing on automation, we introduced it some years back and we're picking up some momentum as well. There's no question in our minds as we track the data That's a contributing factor and that will also contribute continue to contribute.

Speaker 2

As you know, we're certainly not at the end of our opportunities there. And process improvement in general, we've done a lot of work leaning out these labs, working on our processes from The moment the product comes into our facility to the moment it leaves. And I just think that when we look at these processes and Some of the improvements we made, they're contributing factors. So when you look forward and most of the things are going to continue, but I'm always hesitant to guide quarter by quarter on margins Because there's different factors. You get CDLs that can start up and have a short term drag.

Speaker 2

There's other factors as well. So yes, margins will continue to improve. We expect that over time and over the next few years and it will be pretty consistent. I don't want to get into a quarter by quarter guidance on that, but much of what you've seen in the past, I think you'll see in the near future.

Speaker 3

Yes. Okay, fair enough. And then if I could just switch gears to distribution and talk a little bit about What kind of overlap is there? Maybe you can dive into a little bit of the potential revenue And then just in terms of rentals as a mix of total distribution revenue, where does that

Speaker 2

Well, I'll start I'll let Tom talk about Acxiom as a percent of total distribution revenue. I'll talk I'll talk to the synergies, Greg. So there's some really great synergies with this deal and that's why we're excited from the outset. We've got inventories of potential rental equipment on their side of the business that very much will help us with our core customer base and it goes both ways. Our inventory and their inventory, there's some overlap, but not a lot.

Speaker 2

And so we expect to sell our respective inventories to each other's customer base and that's a big one. The way we go to market, Transcat is more driven by our sales are driven by marketing, Robust marketing plans, the domain authority on the web, link equities that we have Where people recognize us from a digital world, they do a lot of traditional selling. So again, this is a synergy because we're going to use our marketing Expertise to help them grow their business and they're going to be using their feet on the street, so to speak, salespeople to help us with ours. So Two great synergies and the customer bases themselves are different. And so I just we like this deal for all those reasons.

Speaker 2

As far as you want to address Tom?

Speaker 1

Yes. So I think, Greg, I mean, if you think of The combined distribution business now, the rentals is 20% to 25% of the combined Distribution now, we take what we had and add the Acxiom business to it.

Speaker 3

And just remind us on the margin structure of rentals

Speaker 1

Yes. I mean, we had when we had acquired Acxiom, we had kind of disclosed that The margins were 55% or better on the rental business, the combined rental business.

Speaker 3

Okay, great. All right. I will leave it there. Thanks. Best of luck.

Speaker 1

Thanks, Greg.

Operator

Our next question is from Ted Jackson with Northland Securities. Please proceed.

Speaker 4

Thank you very much and congrats on a very, very solid quarter.

Speaker 2

Okay. Thanks, Todd. Thanks, Todd.

Speaker 4

I'm going to go into some weeds. Sorry about that, but I always do. You did with the transaction closing and the money that you raised, Clearly wasn't in the current quarter. You're paying off the credit facility. So how much money did actually come in With the deal, I mean, I think it was supposed to be $62,000,000 I mean $65,000,000 or so.

Speaker 4

And then last quarter, the credit facility was at $42,000,000 $43,000,000 So when I Look at your balance sheet, as we kind of think about that, how much cash is on your balance sheet? And am I Correct. I would just take the, call it, 65,000 and subtract out 43,000,000 and you can see that you're going with this and your debt is down by $43,000,000 and then the differentials in cash on your balance sheet.

Speaker 1

Yes. So Ted, it's Tom, right. So we The net proceeds were about $75,000,000 right, because we did the initial deal of $70,000,000

Speaker 2

Oh, you

Speaker 4

had the $10,000,000 that's right.

Speaker 1

Another 10.5 Under the green shoe that was done, right? So we netted about $75,000,000 I'm going to talk round numbers, dollars 50,000,000 of that went to pay off our Credit facility and we've got about $25,000,000 net cash subsequent to that, The revolver being paid off. We've got about $4,500,000 to $5,000,000 of term debt that remains and roughly 4% interest. So that will be the only interest expense we have until we kind of tap into that cash balance.

Speaker 4

Okay. That was very helpful. Any chance you can give me just kind of the breakdown in services between service, 3rd party and freight, at least on a percentage basis, just to let me clean up my model?

Speaker 1

Yes, it's in the queue, which we'll be filing tomorrow. I don't have that off the top of my head, Ted. I apologize.

Speaker 4

That's okay. Then With regards to going back into the margins, because margins were really fabulous. I mean, are we when I think about On the distribution side of margins and the strength you had there, is it just fair to say that with the new mix The rental business that that's kind of the new baseline for distribution margin on a go forward basis?

Speaker 1

Yes. I mean, when we did the acquisition of Acxiom and We said that we expected go forward once we got kind of in the steady state that the distribution margins would be in the 28% to 30% range. So we're kind of already at the low end of that range and we still feel comfortable with that range for distribution in total.

Speaker 4

And then on OpEx, I mean, you actually had some a little better leverage in there than I expected Just in terms of with the different acquisitions and everything that's happened as of late, how should we think about OpEx with regards to at least kind of like A step up from Q2 to Q3 and like kind of how should we think about how that scales out as we go forward?

Speaker 1

Yes. I mean, I think we should expect some continued investments. We've talked about some of the heavy lifting being behind us, but I think we should expect some moderate increases going forward. We continue to invest in sales. We continue to make some investments in IT and cybersecurity, which you just need to do.

Speaker 1

But We believe a lot of the heavy lifting is behind us with the increases that we saw in last year and the year before.

Speaker 4

Okay. And then one last question and then I'll get out of line. On the customer base lab front, can you talk a little bit about kind of Pipeline and activity on that front?

Speaker 2

Yes, I'll take that one, Ted. This is Lee. Yes, the CBL pipeline is Pretty solid. In fact, I would say it's very solid, as solid as it's ever been. We expect that to continue.

Speaker 2

I mean, as long as the labor market is tight And I'm not going to suggest we're the only company that services CBLs, but it's certainly where We have an expertise level in that that is different than our competition. I think we're really well positioned to do well in that space. So I would expect throughout the remainder of this year and into next that the pipeline we have will support strong growth there.

Speaker 4

Okay. I'll get out of line. Again, Greg, congrats on the quarter. Thanks for taking my questions.

Speaker 1

Thank you, Ted. Thank

Operator

you, Ted. Our next question is from Martin Yang with Oppenheimer and Company. Please proceed.

Speaker 5

Good morning. Thank you for taking my question, Lee and Tom. Can you maybe talk about Nexa, give us a sense of how The business has grown by itself and what are synergies, especially revenue synergies you have seen between Nexa and your calibration and distribution Thus far. And finally, maybe the outlook for the Nexa combined with SteroCoral, How that overall consulting business can grow in the longer term? Thanks.

Speaker 2

Okay. So we acquired Nexa, it seems like about 2.5 years ago, roughly. So The business has done really well. We acquired at the time a business that has since doubled in size, more than doubled in size in that period of time. And we think it's performing very well.

Speaker 2

There's a lot of synergies, Martin, that we've been able to leverage, Take advantage of between Transcat and Nexa mostly, but there's 2 avenues of synergies that we've performed well. And one is we've given Nexa access to our customer base and some of that growth since they've more than doubled comes from Transcat traditional customers who are interested in Nexa Services. And that's been very clear and evident synergy for us. The second one has been When Transcat goes to the table and is trying to win a new opportunity, whether it be a CBL or a traditional on-site or a traditional body of work, We have Nexa sitting at the table with us often. And so not only are we talking about winning an opportunity that we currently don't have, that our competition has or an in house lab is running.

Speaker 2

And with Nexus sitting by our side, we're able to strengthen our value proposition. Our chances of winning Increased significantly. We won deals that we would have otherwise not won on the traditional Transcat side because Nexa partnered with us in our proposal. So I think it goes both ways, the synergies have done a really nice job. And I see that continuing and maybe improving as we go forward and get to Know how to work with each other better, get to know each other's companies.

Speaker 2

This is just the early read, and the early read has been strong. SteriQual folds up really nicely under the Nexa suite because Nexa didn't offer commissioning services and now they can. And they do validation as well, which is something that Nexa did offer, but it advances that value proposition. As far as working together, We expect growth to obviously be at a higher rate since we have more to offer and we're not going to guide beyond that at this point other than to say that the outlook With Nexa and Steripol together is stronger than just Nexa by itself because the suite of services has expanded. And Steripol is a really nice small boutique company.

Speaker 2

I think We can help them with some of the traditional ways we run and grow a business. It will be beneficial to them and it's also been beneficial to Nexa. So We expect that trend to continue for those reasons as well. Does that answer your question, Martin?

Speaker 5

Yes. Sorry, I was on mute. Thanks, Lee. So one more question for me is on Gross margin, Acxiom, can you talk about the positive benefit on gross margin due to Acxiom's integration Last quarter and then do you expect a meaningful contribution or gross margin uplift from The full integration of Acxiom in fiscal 3Q.

Speaker 1

Yes. So Martin, the impact in this past quarter It was not significant. We only had 7 weeks in the quarter. So it did positively impact distribution margins, but We'll see more of a full quarter impact in this upcoming quarter, but Our intent is not to really talk about the specifics of margin and distribution and break it down into the individual pieces Kind of on a go forward basis. So we expect, as we've said before, that going forward, we expect distribution margins in total to be in That 28% to 30% range, and we're already in the low end of that range.

Speaker 1

So I think you can kind of take it from there.

Speaker 5

Thank you, Tom. That's all for me.

Operator

And our final question is a Follow-up question from Ted Jackson with Northland Securities. Please proceed.

Speaker 4

Great. Thanks. Hey, I just wanted to touch base on Both automation and kind of what's going on within Ireland, kind of the acquisitions you had in that front. You brought up Automation is one of the drivers for margin. I know it's been an area that you've been focused on and you've kind of been kind of slow and methodical So maybe kind of an update on kinds of things that you're automating and kind of where things stand with regards to that effort.

Speaker 4

And Then behind that kind of the progress report with regards to the penetration of the Irish market? Thanks.

Speaker 2

Okay. First, let's talk about automation and a small subset of that will be robotics. So automation is a very difficult initiative to execute. We knew that going in, but we also knew that once we did it and for each When we made progress, each element of progress that we made with Slow going and arduous, but the results In the last few quarters, you could just see the margins and we can track it back to the number of technicians that we have, how efficient they are. We have productivity ratings For each technician, how often are they on the bench?

Speaker 2

How effective are they when they're on the bench? How much automation are they using? How many calibrations are they doing that are redundant to the time they're spent doing an automated account. These are the type of KPIs we're tracking. So we know it's working and will continue to work.

Speaker 2

What inning are we in? If I had to characterize it, I used to say we're the 1st, 2nd inning. We're probably in the 5th inning of that game Over the that we've progressed from the 1st, 2nd, 3rd inning to the 5th inning, there's still plenty of work to do. Robotics is a subset of that. The Irish company we bought is a robotics company and we are now doing mass calibrations for example in Philadelphia and our LA labs.

Speaker 2

We have 2 robots in each lab. In Ireland, that robotics team, they're now working on digital multimeters. And I think on deck is temperature and pressure after that. So again, not a fast process, but robotics is actually faster than traditional automation. And we've like I said, we've already got robots running.

Speaker 2

And so these are things that are going to help us get to that High-30s from the mid-30s and beyond. That's our ultimate goal. So we're pleased with that progress. The Irish market itself as far as developing it For the calibration business, we bought that very, very small company. We've got some interesting plans in the works to try to grow that organically.

Speaker 2

It's really early for us to get into too many details on that, but we intend on growing our calibration business in the Irish market And really kind of exclusively in the Irish market as far as Europe goes, that's where our Calab is, that's where we'll do work and that's where we'll grow organically. Unlike the Nexa business that's more scalable throughout Europe because it's just easier to grow that business and to follow our customers throughout the European footprint, Calibration will be in Ireland and it's the early days there, but we intend on growing it organically for sure. I hope that's helpful, Ted.

Speaker 4

It was. Thanks very much.

Operator

There are no more questions in the queue. I would like to turn

Speaker 2

Interest in Transcat. As always, we'll be participating in the ROTH and the Craig Hallum Conferences in New York City on November 15 November 16. So feel free Have our 3rd quarter results. Thanks again for participating in today's call.

Operator

Thank you. This will conclude today's conference. You may disconnect your lines at this time and thank you for your participation.

Earnings Conference Call
Transcat Q2 2024
00:00 / 00:00